Security key
19459J104
COLLEGIUM PHARMACEUTICAL, INC - Common Stock (COLL)
CUSIP: 19459J104
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 37,127,091
- Total 13F value
- $1,718,563,197
- Share change
- -11,345
- Put/Call ratio
- 0%
- SEC-reported price per share
- $46.30
- Number of holders
- 278
- Value change
- +$3,842,171
- Number of buys
- 131
- Number of sells
- 122
- Shares outstanding
- 32,451,517
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
278
Top holders
10
COLL full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
COLLEGIUM PHARMACEUTICAL, INC SEC filings
COLLEGIUM PHARMACEUTICAL, INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 19459J104
Recent filing periods:
Ownership snapshot
Top reported holders of COLL - COLLEGIUM PHARMACEUTICAL, INC - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
15/15
Latest evidence
12 Nov 2025
13F
13D/G
3/4/5
Lead comparable stake: 16%
13D/G row: BlackRock, Inc.
Showing 1-6 of 15 holder rows.
Quick read
BlackRock, Inc. leads the comparable SEC ownership view at 16%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership
Top 5
BlackRock, Inc.
16%
Rubric Capital Management LP
4.7%
PRINCIPAL GLOBAL INVESTORS
4.6%
Pacer Advisors, Inc.
1.1%
John A. Fallon MD
0.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
Company
|
16%
from 13D/G
|
$181,179,760
5,178,044 shares
|
— | 30 Sep 2025 |
| Rubric Capital Management LP |
3/4/5
13D/G
13F
10%+ Owner · Company
|
4.7%
from 13D/G
|
$118,574,322
3,132,743 shares
|
-$946,250 | 13 Aug 2025 |
| PRINCIPAL GLOBAL INVESTORS |
13D/G
|
4.6%
|
$44,508,457
1,466,506 shares
|
$0 | 30 Jun 2025 |
| Pacer Advisors, Inc. |
13D/G
13F
Company
|
1.1%
|
$11,222,855
419,076 shares
|
-$46,153,054 | 31 Mar 2025 |
| John A. Fallon MD |
3/4/5
Director
|
0.2%
|
$3,051,603
64,634 shares
|
-$1,645,536 | 12 Nov 2025 |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
Company
|
7.4%
|
$83,653,116
2,390,912 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
278
Shares
37,127,091
Rows available
278
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
241
Q4 2025 holders
278
Holder diff
37
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend